| Literature DB >> 35155390 |
Karina Sałek1, Stephen R Euston2, Tomasz Janek3.
Abstract
Growing demand for biosurfactants as environmentally friendly counterparts of chemically derived surfactants enhances the extensive search for surface-active compounds of biological (microbial) origin. The understanding of the physicochemical properties of biosurfactants such as surface tension reduction, dispersion, emulsifying, foaming or micelle formation is essential for the successful application of biosurfactants in many branches of industry. Glycolipids, which belong to the class of low molecular weight surfactants are currently gaining a lot of interest for industrial applications. For this reason, we focus mainly on this class of biosurfactants with particular emphasis on rhamnolipids and sophorolipids, the most studied of the glycolipids.Entities:
Keywords: biosurfactants; global use of surfactants; glycolipids; lipopeptides; rhamnolipids; sophorolipids
Year: 2022 PMID: 35155390 PMCID: PMC8830654 DOI: 10.3389/fbioe.2022.816613
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Recent reports on possible applications glycolipids.
| Biosurfactant | Biological or Physicochemical activity | Industrial sector | References |
|---|---|---|---|
| Mannosyl erythritol lipids (MELs) | Anti-melanogenic | Cosmetic |
|
| MELs | Anti-bacterial | Foods |
|
| Medical | |||
| MELs | Anti-bacterial | Medical |
|
| Food | |||
| MELs | Nanoparticles | Pharmaceutical |
|
| Sophorolipids | Biofilm inhibition and disruption | Pharmaceutical |
|
| Food | |||
| Packaging | |||
| Acidic sophorolipids | Anti-bacterial activity | Medical |
|
| Free acid and lactonic sophorolipids | Antimicrobial activity and inactivation mechanism against pathogenic | Medical |
|
| Pharmaceutical | |||
| Food | |||
| Lactonic sophorolipids | Solid-lipid nanoparticles | Pharmaceutical |
|
| Sophorolipids | Anti-HIV activity | Medical |
|
| Spermicidal activity | |||
| Sophorolipids | Anti-bacterial | Medical |
|
| Anti-biofilm | Food | ||
| Biomaterial | |||
| Sophorolipids | Anti-cancer (breast adenocarcinoma lines MDA-MB-231) | Medical |
|
| Sophorolipids | Anti-cancer | Medical |
|
| Sophorolipids | Nanoparticle synthesis | Medical |
|
| Mono & di-RLs | Anti-microbial activity | Medical |
|
| Food | |||
| Mono & di-RLs | Cytotoxic effect on human breast cancer cells | Medical |
|
| Rhamnolipids | Stabilisation of oil in high water internal phase emulsions (HIPEs) | Food |
|
| Medical | |||
| Personal care Cosmetics | |||
| Rhamnolipids | Anti-bacterial activity towards food pathogens: | Food |
|
| Packaging | |||
| Rhamnolipids | Nanoemulsions for drug delivery mechanism against SCC7 tumour cells | Medical |
|
| Rhamnolipids | Biodegradation of hydrophobic organic compounds | Bioremediation strategies |
|
| Rhamnolipids | Microbial-enhanced oil recovery (MEOR) | Environmental protection |
|
| Petroleum | |||
| Rhamnolipid | Nanoparticle synthesis | Medical |
|
| Trehalolipids | Anti-microbial | Medical |
|
| Anti-adhesive | Biomaterials | ||
| Trehalolipids | Immunomodulato-ry and membrano- tropic activity | Medical |
|
| Trehalolipids | Anti-tumour | Medical |
|
FIGURE 1Structure of di-acetylated lactonic and acidic sophorolipids (Hardin et al., 2007; Jezierska et al., 2018).
FIGURE 2Structure of mannosylerythritol lipids (n = 6–10) (Konishi et al., 2007a; Yu et al., 2015). MEL-A–R1 = CH3CO, R 2 = CH3CO. MEL-B–R1 = CH3CO, R 2 = H. MEL-C–R1 = H, R 2 = CH3CO MEL-D–R1 = H, R 2 = H.
FIGURE 3Chemical structure of trehalolipid from Rhodococcus sp. (Ortiz et al., 2008).
FIGURE 4General structure of PEFA (Garay et al., 2018). Where: R = OH or acetyl n = 8, 10, 12, 14, 16.